Glendon E. French III - Mar 1, 2022 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
President and CEO, Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Glendon E. French
Stock symbol
LUNG
Transactions as of
Mar 1, 2022
Transactions value $
-$29,330
Form type
4
Date filed
3/3/2022, 05:03 PM
Previous filing
Feb 22, 2022
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$29.3K -1.13K -0.11% $25.91 1.06M Mar 1, 2022 Direct F1
transaction LUNG Common Stock Award $0 +69.7K +6.56% $0.00 1.13M Mar 1, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Employee Stock Option (right to buy) Award $0 +155K $0.00 155K Mar 1, 2022 Common Stock 155K $26.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.
F2 Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2022.
F3 The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022.